Interatrial Shunt
Total Trials
14
As Lead Sponsor
As Collaborator
0
Total Enrollment
3,340
NCT01570517
Feasibility Trial of the DC Devices Interatrial Septal Device (IASD) System
Phase: N/A
Role: Lead Sponsor
Start: May 31, 2012
Completion: Dec 31, 2014
NCT01913613
REDUCE LAP-HF TRIAL
Start: Sep 30, 2013
Completion: Jul 31, 2018
NCT03266029
Clinical Evaluation of Cordio App in Adult ADHF Patients
Start: May 24, 2015
Completion: Dec 10, 2020
NCT03438799
COMMUNITY STUDY- A Study to Collect Information for the Cordio System
Start: Oct 20, 2015
Completion: Apr 30, 2022
NCT02600234
REDUCE LAP-HF RANDOMIZED TRIAL I
Start: Dec 31, 2015
Completion: Aug 31, 2026
NCT03093961
REDUCE LAP-HFREF TRIAL
Start: Mar 10, 2017
Completion: Dec 31, 2027
NCT03088033
REDUCE LAP-HF TRIAL II
Start: Jun 1, 2017
Completion: Sep 30, 2026
NCT03191656
REDUCE LAP-HF III Corvia Protocol 1701
Start: Jul 12, 2017
Completion: Jul 31, 2028
NCT03714126
Remote Speech Analysis in HF Patients Undergoing Haemodialysis
Start: Mar 27, 2019
Completion: Mar 8, 2021
NCT04325048
Clinical Evaluation of Cordio Application in Adult COVID-19 Virus Positive Patients
Start: Apr 23, 2020
Completion: Sep 29, 2021
NCT04632160
Extended IASD Investigation: REDUCE LAP-HF IV
Start: Dec 1, 2021
Completion: Jan 1, 2027
NCT06378632
AN INTERNATIONAL, OBSERVATIONAL, BLINDED STUDY TO ASSESS THE PERFORMANCE OF THE CORDIO HEARO SYSTEM
Start: Feb 11, 2022
Completion: Jul 15, 2025
NCT05876533
R&D Study to Evaluate Cordio's Usability and to Collect Patient Speech Utterances
Start: Mar 18, 2022
Completion: Mar 15, 2025
NCT05425459
RESPONDER-HF Trial
Start: Nov 17, 2022
Completion: Mar 31, 2031
Loading map...